The Imatinib Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Imatinib Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Chronic Myelogenous Leukemia accounting for % of the Imatinib Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Tablets segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Imatinib Drug include Novartis, Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals, Actavis Generics, and Dr. Reddy's Laboratories, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Imatinib Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Tablets
- Capsules
Market segment by Application can be divided into
- Chronic Myelogenous Leukemia
- Gastrointestinal Stromal Tumors
- Others
The key market players for global Imatinib Drug market are listed below:
- Novartis
- Glenmark Pharmaceuticals Ltd.
- Sun Pharmaceuticals
- Actavis Generics
- Dr. Reddy's Laboratories
- Teva Pharmaceutical Industries Ltd.
- Sanofi S.A.
- Cipla Inc.
- Apotex Inc.
- Mylan Pharms Inc.
Market segment by region, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Imatinib Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Imatinib Drug, with price, sales, revenue and global market share of Imatinib Drug from 2019 to 2022.
Chapter 3, the Imatinib Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Imatinib Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Imatinib Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Imatinib Drug.
Chapter 13, 14, and 15, to describe Imatinib Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Global Imatinib Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
Table of Contents
1 Market Overview
1.1 Imatinib Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Imatinib Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Tablets
1.2.3 Capsules
1.3 Market Analysis by Application
1.3.1 Overview: Global Imatinib Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Chronic Myelogenous Leukemia
1.3.3 Gastrointestinal Stromal Tumors
1.3.4 Others
1.4 Global Imatinib Drug Market Size & Forecast
1.4.1 Global Imatinib Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Imatinib Drug Sales in Volume (2017-2028)
1.4.3 Global Imatinib Drug Price (2017-2028)
1.5 Global Imatinib Drug Production Capacity Analysis
1.5.1 Global Imatinib Drug Total Production Capacity (2017-2028)
1.5.2 Global Imatinib Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Imatinib Drug Market Drivers
1.6.2 Imatinib Drug Market Restraints
1.6.3 Imatinib Drug Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Imatinib Drug Product and Services
2.1.4 Novartis Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Glenmark Pharmaceuticals Ltd.
2.2.1 Glenmark Pharmaceuticals Ltd. Details
2.2.2 Glenmark Pharmaceuticals Ltd. Major Business
2.2.3 Glenmark Pharmaceuticals Ltd. Imatinib Drug Product and Services
2.2.4 Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sun Pharmaceuticals
2.3.1 Sun Pharmaceuticals Details
2.3.2 Sun Pharmaceuticals Major Business
2.3.3 Sun Pharmaceuticals Imatinib Drug Product and Services
2.3.4 Sun Pharmaceuticals Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Actavis Generics
2.4.1 Actavis Generics Details
2.4.2 Actavis Generics Major Business
2.4.3 Actavis Generics Imatinib Drug Product and Services
2.4.4 Actavis Generics Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Dr. Reddy's Laboratories
2.5.1 Dr. Reddy's Laboratories Details
2.5.2 Dr. Reddy's Laboratories Major Business
2.5.3 Dr. Reddy's Laboratories Imatinib Drug Product and Services
2.5.4 Dr. Reddy's Laboratories Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Teva Pharmaceutical Industries Ltd.
2.6.1 Teva Pharmaceutical Industries Ltd. Details
2.6.2 Teva Pharmaceutical Industries Ltd. Major Business
2.6.3 Teva Pharmaceutical Industries Ltd. Imatinib Drug Product and Services
2.6.4 Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sanofi S.A.
2.7.1 Sanofi S.A. Details
2.7.2 Sanofi S.A. Major Business
2.7.3 Sanofi S.A. Imatinib Drug Product and Services
2.7.4 Sanofi S.A. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Cipla Inc.
2.8.1 Cipla Inc. Details
2.8.2 Cipla Inc. Major Business
2.8.3 Cipla Inc. Imatinib Drug Product and Services
2.8.4 Cipla Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Apotex Inc.
2.9.1 Apotex Inc. Details
2.9.2 Apotex Inc. Major Business
2.9.3 Apotex Inc. Imatinib Drug Product and Services
2.9.4 Apotex Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Mylan Pharms Inc.
2.10.1 Mylan Pharms Inc. Details
2.10.2 Mylan Pharms Inc. Major Business
2.10.3 Mylan Pharms Inc. Imatinib Drug Product and Services
2.10.4 Mylan Pharms Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Imatinib Drug Breakdown Data by Manufacturer
3.1 Global Imatinib Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Imatinib Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Imatinib Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Imatinib Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Imatinib Drug Manufacturer Market Share in 2021
3.5 Global Imatinib Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Imatinib Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Imatinib Drug Market Size by Region
4.1.1 Global Imatinib Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Imatinib Drug Revenue by Region (2017-2028)
4.2 North America Imatinib Drug Revenue (2017-2028)
4.3 Europe Imatinib Drug Revenue (2017-2028)
4.4 Asia-Pacific Imatinib Drug Revenue (2017-2028)
4.5 South America Imatinib Drug Revenue (2017-2028)
4.6 Middle East and Africa Imatinib Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Imatinib Drug Sales in Volume by Type (2017-2028)
5.2 Global Imatinib Drug Revenue by Type (2017-2028)
5.3 Global Imatinib Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Imatinib Drug Sales in Volume by Application (2017-2028)
6.2 Global Imatinib Drug Revenue by Application (2017-2028)
6.3 Global Imatinib Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Imatinib Drug Sales by Type (2017-2028)
7.2 North America Imatinib Drug Sales by Application (2017-2028)
7.3 North America Imatinib Drug Market Size by Country
7.3.1 North America Imatinib Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Imatinib Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Imatinib Drug Sales by Type (2017-2028)
8.2 Europe Imatinib Drug Sales by Application (2017-2028)
8.3 Europe Imatinib Drug Market Size by Country
8.3.1 Europe Imatinib Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Imatinib Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Imatinib Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Imatinib Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Imatinib Drug Market Size by Region
9.3.1 Asia-Pacific Imatinib Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Imatinib Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Imatinib Drug Sales by Type (2017-2028)
10.2 South America Imatinib Drug Sales by Application (2017-2028)
10.3 South America Imatinib Drug Market Size by Country
10.3.1 South America Imatinib Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Imatinib Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Imatinib Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Imatinib Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Imatinib Drug Market Size by Country
11.3.1 Middle East & Africa Imatinib Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Imatinib Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Imatinib Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Imatinib Drug
12.3 Imatinib Drug Production Process
12.4 Imatinib Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Imatinib Drug Typical Distributors
13.3 Imatinib Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Imatinib Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Imatinib Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Imatinib Drug Product and Services
Table 6. Novartis Imatinib Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Glenmark Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table 8. Glenmark Pharmaceuticals Ltd. Major Business
Table 9. Glenmark Pharmaceuticals Ltd. Imatinib Drug Product and Services
Table 10. Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sun Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Sun Pharmaceuticals Major Business
Table 13. Sun Pharmaceuticals Imatinib Drug Product and Services
Table 14. Sun Pharmaceuticals Imatinib Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Actavis Generics Basic Information, Manufacturing Base and Competitors
Table 16. Actavis Generics Major Business
Table 17. Actavis Generics Imatinib Drug Product and Services
Table 18. Actavis Generics Imatinib Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 20. Dr. Reddy's Laboratories Major Business
Table 21. Dr. Reddy's Laboratories Imatinib Drug Product and Services
Table 22. Dr. Reddy's Laboratories Imatinib Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Teva Pharmaceutical Industries Ltd. Major Business
Table 25. Teva Pharmaceutical Industries Ltd. Imatinib Drug Product and Services
Table 26. Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 28. Sanofi S.A. Major Business
Table 29. Sanofi S.A. Imatinib Drug Product and Services
Table 30. Sanofi S.A. Imatinib Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Cipla Inc. Basic Information, Manufacturing Base and Competitors
Table 32. Cipla Inc. Major Business
Table 33. Cipla Inc. Imatinib Drug Product and Services
Table 34. Cipla Inc. Imatinib Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Apotex Inc. Basic Information, Manufacturing Base and Competitors
Table 36. Apotex Inc. Major Business
Table 37. Apotex Inc. Imatinib Drug Product and Services
Table 38. Apotex Inc. Imatinib Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Mylan Pharms Inc. Basic Information, Manufacturing Base and Competitors
Table 40. Mylan Pharms Inc. Major Business
Table 41. Mylan Pharms Inc. Imatinib Drug Product and Services
Table 42. Mylan Pharms Inc. Imatinib Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Imatinib Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Imatinib Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Imatinib Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Imatinib Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Imatinib Drug Production Site of Key Manufacturer
Table 48. Imatinib Drug New Entrant and Capacity Expansion Plans
Table 49. Imatinib Drug Mergers & Acquisitions in the Past Five Years
Table 50. Global Imatinib Drug Sales by Region (2017-2022) & (K Units)
Table 51. Global Imatinib Drug Sales by Region (2023-2028) & (K Units)
Table 52. Global Imatinib Drug Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Imatinib Drug Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Imatinib Drug Sales by Type (2017-2022) & (K Units)
Table 55. Global Imatinib Drug Sales by Type (2023-2028) & (K Units)
Table 56. Global Imatinib Drug Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Imatinib Drug Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Imatinib Drug Price by Type (2017-2022) & (USD/Unit)
Table 59. Global Imatinib Drug Price by Type (2023-2028) & (USD/Unit)
Table 60. Global Imatinib Drug Sales by Application (2017-2022) & (K Units)
Table 61. Global Imatinib Drug Sales by Application (2023-2028) & (K Units)
Table 62. Global Imatinib Drug Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Imatinib Drug Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Imatinib Drug Price by Application (2017-2022) & (USD/Unit)
Table 65. Global Imatinib Drug Price by Application (2023-2028) & (USD/Unit)
Table 66. North America Imatinib Drug Sales by Country (2017-2022) & (K Units)
Table 67. North America Imatinib Drug Sales by Country (2023-2028) & (K Units)
Table 68. North America Imatinib Drug Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Imatinib Drug Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Imatinib Drug Sales by Type (2017-2022) & (K Units)
Table 71. North America Imatinib Drug Sales by Type (2023-2028) & (K Units)
Table 72. North America Imatinib Drug Sales by Application (2017-2022) & (K Units)
Table 73. North America Imatinib Drug Sales by Application (2023-2028) & (K Units)
Table 74. Europe Imatinib Drug Sales by Country (2017-2022) & (K Units)
Table 75. Europe Imatinib Drug Sales by Country (2023-2028) & (K Units)
Table 76. Europe Imatinib Drug Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Imatinib Drug Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Imatinib Drug Sales by Type (2017-2022) & (K Units)
Table 79. Europe Imatinib Drug Sales by Type (2023-2028) & (K Units)
Table 80. Europe Imatinib Drug Sales by Application (2017-2022) & (K Units)
Table 81. Europe Imatinib Drug Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Imatinib Drug Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Imatinib Drug Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Imatinib Drug Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Imatinib Drug Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Imatinib Drug Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Imatinib Drug Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Imatinib Drug Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Imatinib Drug Sales by Application (2023-2028) & (K Units)
Table 90. South America Imatinib Drug Sales by Country (2017-2022) & (K Units)
Table 91. South America Imatinib Drug Sales by Country (2023-2028) & (K Units)
Table 92. South America Imatinib Drug Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Imatinib Drug Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Imatinib Drug Sales by Type (2017-2022) & (K Units)
Table 95. South America Imatinib Drug Sales by Type (2023-2028) & (K Units)
Table 96. South America Imatinib Drug Sales by Application (2017-2022) & (K Units)
Table 97. South America Imatinib Drug Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Imatinib Drug Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Imatinib Drug Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Imatinib Drug Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Imatinib Drug Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Imatinib Drug Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Imatinib Drug Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Imatinib Drug Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Imatinib Drug Sales by Application (2023-2028) & (K Units)
Table 106. Imatinib Drug Raw Material
Table 107. Key Manufacturers of Imatinib Drug Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Imatinib Drug Typical Distributors
Table 111. Imatinib Drug Typical Customers
List of Figures
Figure 1. Imatinib Drug Picture
Figure 2. Global Imatinib Drug Revenue Market Share by Type in 2021
Figure 3. Tablets
Figure 4. Capsules
Figure 5. Global Imatinib Drug Revenue Market Share by Application in 2021
Figure 6. Chronic Myelogenous Leukemia
Figure 7. Gastrointestinal Stromal Tumors
Figure 8. Others
Figure 9. Global Imatinib Drug Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Imatinib Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Imatinib Drug Sales (2017-2028) & (K Units)
Figure 12. Global Imatinib Drug Price (2017-2028) & (USD/Unit)
Figure 13. Global Imatinib Drug Production Capacity (2017-2028) & (K Units)
Figure 14. Global Imatinib Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Imatinib Drug Market Drivers
Figure 16. Imatinib Drug Market Restraints
Figure 17. Imatinib Drug Market Trends
Figure 18. Global Imatinib Drug Sales Market Share by Manufacturer in 2021
Figure 19. Global Imatinib Drug Revenue Market Share by Manufacturer in 2021
Figure 20. Imatinib Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Imatinib Drug Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Imatinib Drug Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Imatinib Drug Sales Market Share by Region (2017-2028)
Figure 24. Global Imatinib Drug Revenue Market Share by Region (2017-2028)
Figure 25. North America Imatinib Drug Revenue (2017-2028) & (USD Million)
Figure 26. Europe Imatinib Drug Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Imatinib Drug Revenue (2017-2028) & (USD Million)
Figure 28. South America Imatinib Drug Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Imatinib Drug Revenue (2017-2028) & (USD Million)
Figure 30. Global Imatinib Drug Sales Market Share by Type (2017-2028)
Figure 31. Global Imatinib Drug Revenue Market Share by Type (2017-2028)
Figure 32. Global Imatinib Drug Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Imatinib Drug Sales Market Share by Application (2017-2028)
Figure 34. Global Imatinib Drug Revenue Market Share by Application (2017-2028)
Figure 35. Global Imatinib Drug Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Imatinib Drug Sales Market Share by Type (2017-2028)
Figure 37. North America Imatinib Drug Sales Market Share by Application (2017-2028)
Figure 38. North America Imatinib Drug Sales Market Share by Country (2017-2028)
Figure 39. North America Imatinib Drug Revenue Market Share by Country (2017-2028)
Figure 40. United States Imatinib Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Imatinib Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Imatinib Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Imatinib Drug Sales Market Share by Type (2017-2028)
Figure 44. Europe Imatinib Drug Sales Market Share by Application (2017-2028)
Figure 45. Europe Imatinib Drug Sales Market Share by Country (2017-2028)
Figure 46. Europe Imatinib Drug Revenue Market Share by Country (2017-2028)
Figure 47. Germany Imatinib Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Imatinib Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Imatinib Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Imatinib Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Imatinib Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Imatinib Drug Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Imatinib Drug Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Imatinib Drug Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Imatinib Drug Revenue Market Share by Region (2017-2028)
Figure 56. China Imatinib Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Imatinib Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Imatinib Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Imatinib Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Imatinib Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Imatinib Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Imatinib Drug Sales Market Share by Type (2017-2028)
Figure 63. South America Imatinib Drug Sales Market Share by Application (2017-2028)
Figure 64. South America Imatinib Drug Sales Market Share by Country (2017-2028)
Figure 65. South America Imatinib Drug Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Imatinib Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Imatinib Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Imatinib Drug Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Imatinib Drug Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Imatinib Drug Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Imatinib Drug Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Imatinib Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Imatinib Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Imatinib Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Imatinib Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Imatinib Drug in 2021
Figure 77. Manufacturing Process Analysis of Imatinib Drug
Figure 78. Imatinib Drug Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
